Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMASUD : revenue, balance sheet and financial ratios

PHARMASUD is a French company founded 20 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in PORTO-VECCHIO (20137), this company of category PME shows in 2022 a net income positive of 970 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMASUD (SIREN 483194049)
Indicator 2022 2020 2019 2017 2016 2015
Revenue N/C N/C N/C N/C N/C N/C
Net income 970 346 € 385 594 € 182 874 € 189 080 € 260 573 € 58 724 €
EBITDA N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C

Revenue and income statement

Im Jahr 2022 erzielt PHARMASUD ein positives Nettoergebnis von 970 k€. Entwicklung 2015-2022: 59 k€ -> 970 k€.

Net income (2022) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

970 346 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

Die Verschuldungsquote (= Finanzschulden / Eigenkapital x 100) beträgt 45%. Die Verschuldung bleibt unter Kontrolle. Die finanzielle Autonomie (= Eigenkapital / Bilanzsumme x 100) erreicht 54%. Diese hohe Autonomie bedeutet, dass das Unternehmen den Großteil seiner Vermögenswerte durch Eigenkapital finanziert.

Debt ratio (2022) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

45.031%

Financial autonomy (2022) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

54.408%

Asset age ratio (2022) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

37.8%

Solvency indicators evolution
PHARMASUD

Sector positioning

Verschuldungsgrad
45.03 2022
2019
2020
2022
Q1: 24.51
Med: 74.73
Q3: 182.48
Gut -22 pts over 3 years

Im Jahr 2022 liegt unter dem Median der Branche das verschuldungsgrad von PHARMASUD (45.03). Dieses Verhältnis misst das Gewicht der Schulden im Verhältnis zum Eigenkapital. Diese kontrollierte Position spiegelt umsichtiges Management wider.

Finanzielle Autonomie
54.41% 2022
2019
2020
2022
Q1: 28.54%
Med: 47.06%
Q3: 66.62%
Gut +23 pts over 3 years

Im Jahr 2022 liegt über dem Median der Branche das finanzielle autonomie von PHARMASUD (54.4%). Dieses Verhältnis stellt den Anteil des Eigenkapitals an der Gesamtfinanzierung dar. Diese komfortable Position bietet eine nennenswerte Sicherheitsmarge.

Liquidity ratios

Die Liquiditätsquote beträgt 349.68. Das Unternehmen verfügt über 2€ liquide Mittel für jeden 1€ kurzfristiger Schulden.

Liquidity ratio (2022) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

349.68

Liquidity indicators evolution
PHARMASUD

Sector positioning

Liquiditätsquote
349.68 2022
2019
2020
2022
Q1: 145.16
Med: 199.46
Q3: 274.98
Ausgezeichnet +8 pts over 3 years

Im Jahr 2022 liegt in den oberen 25% der Branche das liquiditätsquote von PHARMASUD (349.68). Dieses Verhältnis misst die Fähigkeit, kurzfristige Schulden mit Umlaufvermögen zu decken. Ein Verhältnis über 1 gewährleistet komfortable Deckung kurzfristiger Fälligkeiten.

Positioning of PHARMASUD in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 215 transactions of similar company sales in 2022, the value of PHARMASUD is estimated at 11 417 584 € (range 7 674 885€ - 17 124 256€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2022
215 transactions
7674k€ 11417k€ 17124k€
11 417 584 € Range: 7 674 885€ - 17 124 256€
NAF 5 année 2022

Valuation method used

Net Income Multiple
970 346 € × 11.8x = 11 417 585 €
Range: 7 674 885€ - 17 124 257€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 215 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMASUD with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMASUD

What is the revenue of PHARMASUD ?

The revenue of PHARMASUD is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMASUD profitable?

Yes, PHARMASUD generated a net profit of 970 k€ in 2022.

Where is the headquarters of PHARMASUD ?

The headquarters of PHARMASUD is located in PORTO-VECCHIO (20137).

Where to find the tax return of PHARMASUD ?

The tax return of PHARMASUD is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMASUD operate?

PHARMASUD operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.